Monday, April 15, 2024 4:43:26 PM
OTC Disclosure & News
ActiveInactiveAll
PUBLISH DATE TITLE PERIOD END DATE STATUS
04/15/2024 Quarterly Report - Itonis's Quarterly Report, ending February 29, 2024 02/29/2024 A
03/25/2024 Attorney Letter with Respect to Current Information - Attorney letter with respect to ITNS current information, corrected 11/30/2023 A
03/20/2024 Attorney Letter with Respect to Current Information - Attorney Letter with respect to Current Information, Itonis, ending Nov 30, 2023 11/30/2023 A
01/16/2024 Annual Report - Itonis' Annual Report, ending November 30, 2023 11/30/2023 A
01/16/2024 Quarterly Report - Itonis' Quarterly Report, ending August 31, 2023 08/31/2023 A
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM